Bayer Receivables 2010-2025 | BAYRY

Bayer receivables for the quarter ending March 31, 2025 were $17.638B, a 8.7% decline year-over-year.

  • Bayer receivables for 2024 were $13.524B, a 2.49% decline from 2023.
  • Bayer receivables for 2023 were $13.87B, a 4.21% decline from 2022.
  • Bayer receivables for 2022 were $14.479B, a 7.86% decline from 2021.

Bayer Receivables 2010-2025 | BAYRY

  • Bayer receivables for 2024 were $13.524B, a 2.49% decline from 2023.
  • Bayer receivables for 2023 were $13.87B, a 4.21% decline from 2022.
  • Bayer receivables for 2022 were $14.479B, a 7.86% decline from 2021.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$751.6B
Johnson & Johnson (JNJ)$377.5B
AbbVie (ABBV)$339.9B
Novo Nordisk (NVO)$307.8B
Roche Holding AG (RHHBY)$258.2B
Novartis AG (NVS)$255.6B
Merck (MRK)$209.3B
Pfizer (PFE)$145.8B
Sanofi (SNY)$119.2B
Innoviva (INVA)$1.2B